Indeed, we and others have shown that ANCO1 can alter transcription by interacting with histone acetylation-modifying proteins [10,11,13] and binding and suppressing oncogenic transcriptional complexes, such as TEAD/YAP/AIB1, to halt tumor initiation and progression [6]. This evidence concerns the gene NCOA3 and neoplasm.